IPA CJC-1295 is a synthetic peptide that has been explored in research for its potential role in stimulating growth hormone release. Unlike some shorter-acting analogs, CJC-1295 with DAC (Drug Affinity Complex) is designed to provide longer-lasting effects by binding to albumin in the bloodstream, which may extend its half-life. Research suggests this prolonged activity could make it useful for studying sustained growth hormone secretion, tissue repair, and possible impacts on muscle development and recovery.
Another area of interest in research on CJC-1295 is its potential to influence cellular repair and overall vitality. By stimulating growth hormone pathways, it has been associated in studies with improved protein synthesis, potential fat metabolism benefits, and enhanced recovery times after stress or injury. These possible outcomes make it a subject of ongoing scientific investigation for applications related to longevity, performance, and healing.
125 $
Fast Shipping
Most orders are processed out the same day they are placed.
It is important to emphasize that CJC-1295, including IPA formulations, is for research purposes only. It is not approved for human use or consumption, and its potential effects, safety profile, and long-term implications require further controlled study before any clinical applications can be determined.
Application
• Lean Muscle Growth, Increased Tissue Repair, Recovery, Performance • Speeds Up Tissue Regeneration • Reduces Inflammation • Improves Gut Health • Relieves Joint Pain • Boosts Immune Function • Improves Muscle Strength and Endurance • Supports Growth Hormone Release • May Enhance Protein Synthesis and Fat Metabolism
Appearance
N/A
Chemical Formula
N/A
PubChem CID
N/A
CAS Number
N/A
Molecular Weight
10mg
Synonyms
IPA CJC-1295 • CJC-1295 with DAC • Growth Hormone Releasing Peptide Analog
